Antigenicity of sulfanilamide and its metabolites using fluorescent-labelled compounds

Xenobiotica

Volumn 35, Issue 9, 2005, Pages 911-925

  Eyanagi, R ^a   Toda, A ^a   Ishii, Y ^b   Saito, H ^a   Soeda, S ^c   Shimeno, H ^c   Shigematsu, H ^a  

^a DAIICHI UNIVERSITY OF PHARMACY   (Japan)

^b KYUSHU UNIVERSITY   (Japan)

^c FUKUOKA UNIVERSITY   (Japan)

Author keywords

Carrier protein; Dansylation; Glutathione; Hydroxylamine; Nitroso; Sulfanilamide

Indexed keywords

5 DIMETHYLAMINO N (4 AMINOBENZYL)NAPHTHALENESULFONAMIDE; 5 DIMETHYLAMINO N (4 HYDROXYAMINOBENZYL) 1 NAPHTHALENESULFONAMIDE; 5 DIMETHYLAMINO N (4 NITROSOBENZYL) 1 NAPHTHALENESULFONAMIDE; AMINO ACID; FATTY ACID BINDING PROTEIN; FLUORESCENT DYE; GLUTATHIONE; GLUTATHIONE TRANSFERASE; HAPTEN; HORSERADISH PEROXIDASE; RETINOL DEHYDROGENASE; SULFANILAMIDE; SULFANILAMIDE DERIVATIVE; SULFANILAMIDE HYDROXYLAMINE; UBIQUITIN; UNCLASSIFIED DRUG;

AMINO ACID ANALYSIS; AMINO TERMINAL SEQUENCE; ANIMAL CELL; ANIMAL TISSUE; ANTIGENICITY; ARTICLE; COMPLEX FORMATION; CONJUGATION; CONTROLLED STUDY; CORRELATION ANALYSIS; DRUG DETERMINATION; DRUG HYPERSENSITIVITY; DRUG PROTEIN BINDING; ERYTHEMA; GUINEA PIG; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; LIVER CYTOSOL; LIVER MICROSOME; NONHUMAN; PROTEIN PURIFICATION; PROTON NUCLEAR MAGNETIC RESONANCE; RAT; SKIN MANIFESTATION;

ANIMALS; ANTI-INFECTIVE AGENTS; DRUG HYPERSENSITIVITY; GUINEA PIGS; MALE; METABOLIC DETOXICATION, DRUG; MICROSOMES, LIVER; RATS; RATS, WISTAR; SULFANILAMIDES;

ANIMALIA; ARMORACIA RUSTICANA; CAVIA; CAVIA PORCELLUS;

EID: 28744445468     PISSN: 00498254     EISSN: 13665928     Source Type: Journal    
DOI: 10.1080/00498250500251533     Document Type: Article

References (33)

1. Bhargava MM, Listowsky I, Arias IM. 1978. Ligandin, bilirubin binding and glutathione-S-transferases activity are independent processes. Journal of Biological Chemistry 53:4112-4115.
2. Chai X, Boerman MHEM, Zhai Y, Napoli JL. 1995. Cloning of a cDNA for liver microsomal retinol dehydrogenase. A tissue-specific, short-chain alcohol dehydrogenase. Journal of Biological Chemistry 270:3900-3904.
3. Chovan LE, Black-Schaefer C, Dandliker PJ, Lau YY. 2004. Automatic mass spectrometry methods development for drug discovery: Application in metabolic stability assays. Rapid Communications in Mass Spectrometry 18:3105-3112.
4. Cirstea M, Cirj M, Suhaciu GH, Petec G, Vacariu A, Mihaileanu M. 1982. Spontaneous formaion of immunogenic conjugates by a biotrans-formation product of sulfanilamide. Revue Roumaine de Morphologie, D'Embryologie et de Physiologie Serie Physiologie 18:175-180.
5. Clarke B, Golman K, Lerche MH, Looker M, O'Sullivan M, Santos A, Servin R, Thaning M. 2003. Hyperpolarization-based methods and compound mixtures for determining protein activity using NMR spectroscopy, and use in determining drug-drug interactions and phenotyping. International Application Published under the Patent Cooperation Treaty.
6. Cribb AE, Spielberg SP. 1990. Hepatic microsomal metabolism of sulfamethoxazole to the hydroxylamine. Drug Metabolism and Disposition 18:784-787.
7. Cribb AE, Miller M, Leeder JS, Hill J, Spielberg SP. 1991. Reactions of the nitroso and hydroxylamine metabolites of sulfamethoxazole with reduced glutathione. Implication for idiosyncratic toxicity. Drug Metabolism and Disposition 19:900-906.
8. Cribb AE, Pohl LR, Spielberg SP, Leeder JS. 1997. Patients with delayed-onset sulfonamide hypersensitivity reactions. Have antibodies recognizing endoplasmic reticulum luminal proteins. Journal of Pharmacology and Experimental Therapeutics 282:1064-1072.
9. Eyanagi R, Hisanari Y, Shigematsu H. 1992. Study on the skin allergy induced by sulfanilamide: Antigenicity of 3-hydroxysulfanilamide. Hifu 34:37-41.
10. Eyanagi R, Hisanari Y, Shigematsu H, Yoshida K. 1989. Metabolism of sulfanilamide by the skin. Hifu 31:164-169.
11. Eyanagi R, Hisanari Y, Shigematsu H. 1991. Studies of paracetamol/phenacetin toxicity: Isolation and charaterization of p-aminophenol-glutathione conjugate. Xenobiotica 21:793-803.
12. Eyanagi R, Hisanari Y, Shigematsu H, Yoshida K, Yoshimura H. 1982. Enhancement of sulfanilamide N-hydroxylase activity in kidney and liver microsomes of rats by pretreatment with 3-methylcholanthrene type polychlorinated biphenyl. Journal of Pharmacobio-Dynamics 5:853-858.
13. Eyanagi R, Yoshida K, Yamamoto I. 1979. Experimental studies on the antigenicity of some metabolites and related compounds of sulfanilamide. Yakugaku Zasshi 99:458-465.
14. Gill HJ, Hough SJ, Naisbitt DJ, Maggs JL, Kitteringham NR, Pirmohamed M, Park BK. 1997. The relationship between the disposition and immunogenicity of sulfamethoxazole in the rat. Journal of Pharmcology and Experimental Therapeutics 282:795-801.
15. Greenberger PA, Pateson R. 1987. Management of drug allergy in patients with the acquired-immunodeficiency syndrome. Journal of Allergy and Clinical immunology 79:484-488.
16. Gruchalla RS, Pesenko RD, Do TT, Skiest DJ. 1998. Sulfonamide-induced reactions in desensitized patients with AIDS - The role of covalent protein haptenation by sulfamethoxazole. Journal of Allergy and Clinical Immunology 101:371-378.
17. Hershko A. 1988. Ubiquitin-mediated protein degradation. Journal of Biological Chemistry 263:15237-15240.
18. Imaoka S, Wan J, Chow T, Hiroi T, Eyanagi R, Shigematsu H, Funae Y. 1998. Cloning and characterization of the CYP2D1-binding protein, retinol dehydrogenase. Archives of Biochemistry and Biophysics 353:331-336.
19. Kamei K, Oshino R, Hara S. 1990. Amino acid sequence of glutathione S-transferase b from guinea pig liver. Journal of Biochemistry 107:111-117.
20. Lorwy OH, Rosebrough NJ, Farr AL, Randall RJ. 1951. Protein mesurement with the Folin phenol reagent. Journal of Biological Chemistry 193:265-275.
21. Manchanda T, Hess D, Dale L, Ferguson SG, Rieder MJ. 2002. Haptenation of sulfonamide reactive metabolites to cellular proteins. Molecular Pharmacology 62:1011-1026.
22. + T cells in individuals allergic to sulfonamides, phenytoin, and carbamazepine. Journal of Immunology 155:462-472.
23. Meekins CV, Sullivan TJ, Gruchalla RS. 1994. Immunochemical analysis of sulfonamide drug allergy: Identification of sulfamethoxazole-substitutied human serum proteins. Journal of allergy and clinical immunology 94:1017-1024.
24. Naisbitt DJ, Gordon SF, Pirmohamed M, Burkhart C, Cribb AE, Pichler WJ, Park BK. 2001. Antigenicity and immunogenicity of sulphamethoxazole: Demonstration of metabolism-dependent haptenation and T-cell proliferation in vivo. British Jounal of Pharmacology 133:295-305.
25. Naisbitt DJ, Hough SJ, Gill HJ, Pirmohamed M, Kitteringham NR, Park BK. 1999. Cellular disposition of sulphamethoxazole and its metabolites: Implications for hypersensitivity. British Jounal of Pharmacology 126:1393-1407.
26. Nose A, Kudo T. 1981. Reduction with sodium borohydride-transition metal salt systems. I. Reduction of aromatic nitro compounds with the sodium borohydride-nickelous chloride system. Chemical and Pharmaceutical Bulletin 29:1159-1161.
27. Oshino R, Kamei K, Nishioka M, Shin M. 1990. Purification and characterization of glutathione S-trasferases from guinea pig liver. Journal of Biochemistry 107:105-110.
28. Rieder MJ, Krause R, Bird IA. 1995. Time-course of toxicity of reactive sulfonamide metabolites. Toxicology 95:141-146.
29. Uetrecht JP. 1985. Reactivity and possible significance of hydroxylamine and nitroso metabolites of procainamide. Journal of Pharmacology and Experimental Therapeutics 232:420-425.
30. Varshavsky A. 1992. The N-end rule. Cell 69:725-735.
31. Veerkamp JH, Peeters RA, Maatman RGHJ. 1991. Structural and functional features of different types of cytoplasmic fatty acid-binding proteins. Biochimica et Biophysica Acta 1081:1-24.
32. Yamamoto I, Eyanagi R. 1977. Positive skin reaction induced by 4,4′-azoxy-benzene disulfonamide in relationship to the sulfanilamide allergy. International Archives of Allergy and Applied Immunology 54:538-541.
33. Zanni MP, Von Greyerz S, Schnyder B, Brander KA, Frutig K, Hari Y, Valitutti S, Pichler WJ. 1998. HLA-restricted processing- and metabolism-independent pathway of drug recognition by human alpha beta T lymphocytes. Journal of Clinical Investigation 102:1591-1598.